{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:47:58Z","timestamp":1760888878620},"reference-count":16,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3960\/jslrt.53.207","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T22:47:47Z","timestamp":1387925267000},"page":"207-213","source":"Crossref","is-referenced-by-count":4,"title":["Eosinophilia and Bone Lesion as Clinical Manifestations of Aggressive Systemic Mastocytosis"],"prefix":"10.3960","volume":"53","author":[{"given":"Emiko","family":"Sakane-Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichi","family":"Kodaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Tsunemine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminari","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kusama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisako","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Horny HP, Metcalfe DD, Bennett JM, Bain BJ, Akin C, <I>et al<\/I>.: Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <I>et al<\/I>. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.54-63, 2008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Pardanani A: Systemic mastocytosis in adults : 2012 Update on diagnosis, risk stratification, and management. Am J Hematol 87:401-411, 2012","DOI":"10.1002\/ajh.23134"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Valent P, Sperr WR, Akin C: How I treat patients with advanced systemic mastocytosis. Blood 116:5812-5817, 2010","DOI":"10.1182\/blood-2010-08-292144"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Sperr WR, Valent P: Diagnosis, progression patterns and prognostication in mastocytosis. Expert Rev Hematol 5:261-274, 2012","DOI":"10.1586\/ehm.12.12"},{"key":"5","unstructured":"5 B&ouml;hm A, F&ouml;dinger M, Wimazal F, Haas OA, Mayerhofer M, <I>et al<\/I>.: Eosinophilia in systemic mastocytosis: Clinical and molecular correlates and prognostic significance. J Allergy Clin Immunol 120:192-199, 2007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Tefferi A, Gotlib J, Pardanani A: Hypereosinophilic syndrome and clonal eosinophilia: Point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 85:158-164, 2010","DOI":"10.4065\/mcp.2009.0503"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Barete S, Assous N, de Gennes C, Grandpeix C, Feger F, <I>et al<\/I>.: Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis 69:1838-1841, 2010","DOI":"10.1136\/ard.2009.124511"},{"key":"8","unstructured":"8 Galli SJ, Metcalfe DD, Arber DA, Dvorak AM: Basophils and mast cells and their disorders. In: Kaushansky K, Lichtman M, Beutler E, Kipps T, Prchal J, <I>et al<\/I>. (eds): Williams Hematology. 8th ed, McGraw-Hill, pp.915-932, 2010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Pardanani A, Tefferi A: Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature. Curr Opin Hematol 17:125-132, 2010","DOI":"10.1097\/MOH.0b013e3283366c59"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, <I>et al<\/I>.: A tyrosine kinase created by fusion of the <I>PDGFRA<\/I> and <I>FIP1L1<\/I> genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348:1201-1214, 2003","DOI":"10.1056\/NEJMoa025217"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Maric I, Robyn J, Metcalfe DD, Fay MP, Carter M, <I>et al<\/I>.: KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1\/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. J Allergy Clin Immunol 120:680-687, 2007","DOI":"10.1016\/j.jaci.2007.05.024"},{"key":"12","unstructured":"12 Takahashi T, Nakamura K, Nishikawa S, Tsuyuoka R, Suzuki A, <I>et al.<\/I>: Interleukin-5 in eosinophilic gastroenteritis. Am J Hematol 40:295-298, 1992"},{"key":"13","unstructured":"13 Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, <I>et al<\/I>.: Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113:5727-5736, 2009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ho LM, Lipper MH: Mastocytosis of the axial skeleton presenting as an epidural mass lesion: MR imaging appearance. AJR Am J Roentgenol 167:716-718, 1996","DOI":"10.2214\/ajr.167.3.8751688"},{"key":"15","unstructured":"15 Ohnishi K, Torimoto Y, Itabashi K, Inamura J, Shindo M, <I>et al<\/I>.: Case of intraspinal epidural tumor developing after systemic mastocytosis with marked osteosclerosis and myelofibrosis. Rinsho Ketsueki 46:1146-1151, 2005 (<I>in Japanese<\/I>)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Quint&aacute;s-Cardama A, Jain N, Verstovsek S: Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis. Cancer 117:5439-5449, 2011","DOI":"10.1002\/cncr.26256"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T08:36:04Z","timestamp":1688891764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/53\/3\/53_207\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.53.207","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}